Cas:1010422-53-3 3-Bromo-2-methyl-6-(trifluoromethyl)pyridine manufacturer & supplier

We serve Chemical Name:3-Bromo-2-methyl-6-(trifluoromethyl)pyridine CAS:1010422-53-3 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.

3-Bromo-2-methyl-6-(trifluoromethyl)pyridine

Chemical Name:3-Bromo-2-methyl-6-(trifluoromethyl)pyridine
CAS.NO:1010422-53-3
Synonyms:Pyridine, 3-bromo-2-methyl-6-(trifluoromethyl)-;3-Bromo-2-methyl-6-(trifluoromethyl)pyridine
Molecular Formula:C7H5BrF3N
Molecular Weight:240.020
HS Code:

Physical and Chemical Properties:
Melting point:N/A
Boiling point:186.7±35.0 °C at 760 mmHg
Density:1.6±0.1 g/cm3
Index of Refraction:1.475
PSA:12.89000
Exact Mass:238.955734
LogP:2.93

Material Safety Information (Applicable for Hazard Chemicals)
RIDADR:
Packing Group:


Contact us for information like Pyridine, 3-bromo-2-methyl-6-(trifluoromethyl)- chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,3-Bromo-2-methyl-6-(trifluoromethyl)pyridine physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,Pyridine, 3-bromo-2-methyl-6-(trifluoromethyl)- Use and application,3-Bromo-2-methyl-6-(trifluoromethyl)pyridine technical grade,usp/ep/jp grade.


Related News: When using the raw materials, as an API manufacturer we produce API in the large reactor in our plant. 3-Bromo-2-methyl-6-(trifluoromethyl)pyridine manufacturer These mathematical dosing algorithms were developed in the Damiano Lab at Boston University and refined based on results from home-use clinical trials in adults and children with T1D. Beta Bionics is a Certified B Corporation? whose founders �� in addition to Ed Damiano �� include other parents of children with type 1 diabetes and people with type 1 diabetes. Beta Bionics is committed to acting in the best interests of the diabetes community and to profoundly disrupting the diabetes medical device industry by bringing the iLet to market as expeditiously and responsibly as possible. 3-Bromo-2-methyl-6-(trifluoromethyl)pyridine supplier This time frame optimizes the opportunity to respond to treatment with an HMA prior to declaring treatment failure, as per NCCN Guidelines. Patients are randomized at a 2:1 ratio into two study arms: IV rigosertib plus Best Supportive Care versus Physician��s Choice plus Best Supportive Care. 3-Bromo-2-methyl-6-(trifluoromethyl)pyridine vendor When using the raw materials, as an API manufacturer we produce API in the large reactor in our plant. 3-Bromo-2-methyl-6-(trifluoromethyl)pyridine factory Once they have decided how to make the compound, our staff in the production department manufacture a high quantity of APIs using the large reactors in our plant.